<DOC>
	<DOCNO>NCT00096616</DOCNO>
	<brief_summary>The purpose study demonstrate superior bronchodilator efficacy inhale Combivent® CFC MDI vs. Albuterol HFA MDI moderate severe asthma patient .</brief_summary>
	<brief_title>Combivent® CFC Metered Dose Inhaler ( MDI ) Moderate Severe Asthma</brief_title>
	<detailed_description />
	<mesh_term>Asthma</mesh_term>
	<mesh_term>Albuterol</mesh_term>
	<criteria>Patient great equal 18 year age , nonsmoker , diagnose asthma , FEV1 le equal 70 percent predict normal , stable use Beta agonist daily use inhaled steroid one year Patients significant disease asthma , require oxygen , intubate within 5 year , asthma exacerbation within 6 week trial , use unstable dos ( great 10 mg/day prednisone equivalent ) steroid , participate another interventional trial</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2013</verification_date>
</DOC>